Fallout from Iran's actions were to an extent priced in by markets
Amid the ongoing third wave of the Covid-19 pandemic, the Drug Regulatory Authority of Pakistan (DRAP) has approved China's Sinovac vaccine against the virus for emergency use, the National Institute of Health in Islamabad announced.
According to a statement released by DRAP, the CoronaVac vaccine developed by Chinese pharmaceutical company Sinovac has been given emergency use authorisation for people aged 18 and above, Xinhua news agency reported.
The statement said the authorisation will be reviewed every quarter keeping in view data regarding safety, efficacy and quality of the vaccine.
It is the third Chinese Covid-19 vaccine to be approved by the country after Sinopharm and CanSino vaccines.
Pakistan kicked off its vaccination drive in early February upon receiving vaccine donation from China.
So far, Pakistan has reported 710,829 confirmed cases with 15,229 deaths.
Fallout from Iran's actions were to an extent priced in by markets
DXB said in a statement that airport 'recovery will take some time' after there was flooding caused by rainwater on the runway
The 22-time Grand Slam title winner was returning to action for the first time after missing most of the 2023 season
For the company's founders, it was a way to give back to the community
Unlocking Holistic Health: Camp to address all acute and chronic issues
Pizza Di Rocco expands into new communities
World No 3 focused on winning in Stuttgart, Madrid or Rome to get a title on the surface under her belt
Roads were shut and stern warnings were issued as the country experienced extreme weather conditions